Your browser doesn't support javascript.
loading
Ruxolitinib is an effective steroid sparing agent in bronchiolitis obliterans due to chronic graft-versus-host-disease.
Streiler, Christopher; Shaikh, Faizan; Davis, Christian; Abhyankar, Sunil; Brownback, Kyle R.
Afiliação
  • Streiler C; Division of Pulmonary, Critical Care, and Sleep Medicine, University of Kansas, 3901 Rainbow Blvd. MS 3007, Kansas City, KS, USA. cstreiler@kumc.edu.
  • Shaikh F; Division of Pulmonary, Critical Care, and Sleep Medicine, University of Kansas, 3901 Rainbow Blvd. MS 3007, Kansas City, KS, USA.
  • Davis C; University of Kansas School of Medicine, Kansas City, KS, USA.
  • Abhyankar S; Department of Hematologic Malignancies and Cellular Therapeutics, University of Kansas, Kansas City, KS, USA.
  • Brownback KR; Division of Pulmonary, Critical Care, and Sleep Medicine, University of Kansas, 3901 Rainbow Blvd. MS 3007, Kansas City, KS, USA.
Bone Marrow Transplant ; 55(6): 1194-1196, 2020 06.
Article em En | MEDLINE | ID: mdl-31484991

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bronquiolite Obliterante / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bronquiolite Obliterante / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article